Startups
2022
ORIKINE BIO SLImproving cytokines with a unique Foldikine technology for their use in clinics
Address
Carrer del Doctor Aiguader 88, 08003 Barcelona, Spain
Social Media

Finance Data

DateInvestorsAmountStage 
Jul 20235.500.000 €Seed

Financial Overview

No revenue recorded yet
Seed

CERCA ownership

Other Catalan Public owners

Logo

Status & Deeptech areas

Company Status & Company Deeptech Areas

Current company status

Current company status

DeepTech Area

DeepTech Area

Spinoff information

Company Description

Orikine Bio is a pioneering biotech company dedicated to advancing the field of engineered cytokines with unparalleled biological features for the treatment of immune-mediated diseases. Our core mission is to unlock the untapped potential of cytokines, enabling us to offer transformative therapies that have the power to reshape the lives of patients around the globe.

Product description

Initial focus is on anti-inflammatory and regenerative auto-inflammatory and auto-immune diseases with potential to extend to other cytokines and diseases such as cancer and allergy.